Reminder: Martek to Host Investor Conference Call to Discuss Research Presented at...

Reminder: Martek to Host Investor Conference Call to Discuss Research
Presented at the International Conference on Alzheimer's Disease in Vienna,
Austria

COLUMBIA, Md., July 13/PRNewswire-FirstCall/ --Martek Biosciences Corporation
(Nasdaq: MATK) will conduct a conference call for investors to discussDHA
research recently presented at the International Conference on Alzheimer's
Disease. The call will take place July 13, 2009, at approximately 9 a.m.
Eastern Time (ET). All interested parties may listen to the call live via
webcast by visiting Martek's web site at http://investors.martek.com.

An archived webcast of the conference call will be available on the Martek's
website for thirty days. In addition, a recorded playback of the call will be
available for one week and can be accessed by calling 800-633-8284 or
402-977-9140 and entering pass code 214 31512.

Martek Biosciences Corporation is a leader in the innovation and development
of DHA omega-3 products that promote health and wellness through every stage
of life. The Company produces life'sDHA(TM), a sustainable and vegetarian
source of DHA omega-3, for use in foods, beverages, infant formula and
supplements, and life'sARA(TM) (arachidonic acid), an omega-6 fatty acid, for
use in infant formula. For more information on Martek Biosciences, visit
http://www.martek.com/.
CONTACT

Kyle Stults
Investor Relations
(410) 740-0081
investors@martek.com

SOURCE Martek Biosciences Corporation

Kyle Stults, Investor Relations, Martek Biosciences Corporation,
+1-410-740-0081, investors@martek.com